Table 2. Association between GrimAA and cognitive function.
Analysis type | Stroop test | RAVLT long delay recall | DSST | |||||||||
Coefficient (95% CI) | p | Adj.p1 | n | Coefficient (95% CI) | p | Adj.p1 | n | Coefficient (95% CI) | p | Adj.p1 | n | |
5-year prospective analysis2 (Y20 epigenetic aging vs. Y25 Cognition) |
0.194 (0.050,0.338) | 0.009 | 0.013 | 925 | -0.046 (-0.087,-0.005) | 0.028 | 0.028 | 932 | -0.308 (-0.505,-0.110) | 0.002 | 0.007 | 931 |
15-year prospective analysis2 (Y15 epigenetic aging vs. Y30 Cognition) |
0.231 (0.069,0.394) | 0.005 | 0.008 | 890 | -0.048 (-0.091,-0.005) | 0.029 | 0.029 | 905 | -0.404 (-0.614,-0.195) | <0.001 | <0.001 | 906 |
Delta analysis (5-year change in GrimAA vs. 5-year change in cognition) |
0.006 (-0.159, 0.170) | 0.946 | 0.946 | 741 | 0.049 (0.000,0.098) | 0.049 | 0.147 | 754 | 0.076 (-0.093, 0.245) | 0.380 | 0.569 | 754 |
1BH-FDR adjustment was applied to account for multiple testing for each aging marker across all the cognitive function tests.
2Multiple linear regression models adjusting for age, sex, race, study fields, and education. Beta coefficients indicate changes in cognitive function score by one year greater in GrimAA.